More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 5 of the 23 sources its claims cite were checked for support.
Abstract
COVID-19 can involve persistence, sequelae, and other medical complications that last weeks to months after initial recovery. This systematic review and meta-analysis aims to identify studies assessing the long-term effects of COVID-19. LitCOVID and Embase were searched to identify articles with original data published before the 1st of January 2021, with a minimum of 100 patients. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. PRISMA guidelines were followed. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included (age 17-87 years). The included studies defined long-COVID as ranging from 14 to 110 days post-viral infection. It was estimated that 80% of the infected patients with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). Multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care.
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis identified 55 long-term effects of COVID-19 across 15 studies including 47,910 patients, estimating that 80% of infected patients developed one or more long-term symptoms. The most common reported effects were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%).
## Key findings
- The review screened 18,251 publications and included 15 studies; together they covered 47,910 patients aged 17–87 years.
- The authors identified 55 long-term effects of COVID-19 and performed 21 meta-analyses.
- Overall, an estimated 80% (95% CI 65–92) of COVID-19 patients had at least one long-term symptom.
- The five most common manifestations were fatigue (58%, 95% CI 42–73), headache (44%, 95% CI 13–78), attention disorder (27%, 95% CI 19–36), hair loss (25%, 95% CI 17–34), and dyspnea (24%, 95% CI 14–36).
- Among laboratory/imaging findings, abnormal chest X-ray/CT was observed in 34% (95% CI 27–42), with elevated D-dimer in 20% (95% CI 6–39) and NT-proBNP in 11% (95% CI 6–17).
## Methods
- Systematic review and meta-analysis following PRISMA guidelines; searches were run in LitCOVID and Embase for original studies published before January 1, 2021.
- Inclusion criteria required peer-reviewed English-language human studies with at least 100 patients and post-COVID-19 outcomes assessed 2 weeks or more after initial symptoms.
- Data extraction and study quality assessment were done by multiple reviewers; pooled prevalences were estimated with random-effects meta-analysis in MetaXL for outcomes reported in at least two studies, with heterogeneity assessed using I².
## Limitations
- The paper states that some outcomes had small sample sizes, limiting generalizability to the general population.
- It notes substantial heterogeneity across studies, mainly due to different follow-up times and mixed severity groups; it was also impossible to determine how long each symptom lasted.
- The paper states that many studies used self-reported questionnaires, creating possible reporting bias, and that outcomes may have been missed because studies used internally pre-defined symptom lists.
- Evident from the text: only English-language studies with at least 100 patients were included, so the review may miss smaller or non-English studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
5 Valid · 0 Not valid · 8 Not checked · 41 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a study reported high levels of depression, anxiety, and post-traumatic stress disorder (PTSD)37 in the long term in patients previously infected with other coronaviruses.”
§ More than 50 long-term effects of COVID-19: a systematic review and meta-analysis > Discussion
What the sources say
- Supportedcites [37] Rogers, J. P. et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7, 611–627. https://doi.org/10.1016/S2215-0366(20)30203-0 (2020). source
The Results report post-illness prevalence of anxiety disorders (14.8%), depression (14.9%), and PTSD (32.2%) among people who recovered from SARS or MERS, with mean follow-up times of 11.6, 22.6, and 33.6 months, respectively. The Discussion describes these prevalences as high, while cautioning that the studies could not clearly separate effects of infection from other factors. Page numbers were not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Fatigue (58%) is the most common symptom of long and acute COVID-1923.”
§ More than 50 long-term effects of COVID-19: a systematic review and meta-analysis > Discussion
What the sources say
- Partly supportedcites [23] Townsend, L. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 15, e0240784. https://doi.org/10.1371/journal.pone.0240784 (2020). sourceExperimental — accuracy not yet measured
Townsend et al. (2020) support only that fatigue is common: the Introduction states it is 'recognised as one of the most common presenting complaints' in SARS-CoV-2 infection, with 44–69.6% in early case series and 34–46% in meta-analyses — figures the paper credits to other works it cites, and it never ranks fatigue as THE most common symptom of acute disease. For the convalescent/'long' COVID side, the Results (Prevalence of post-COVID fatigue) report 52.3% (67/128) meeting the CFQ-11 case definition at a median of 10 weeks, and the paper reports no symptom-prevalence comparison, so it does not establish fatigue as the most common long-COVID symptom either. The specific 58% magnitude attributed here matches nothing in our copy (the only nearby percentages are 52.3% fatigued cases and 57% of those offered an appointment who attended), so both the superlative and the number are unsupported. (LLM, conf=0.80)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It is present even after 100 days of the first symptom of acute COVID-194,23.”
§ More than 50 long-term effects of COVID-19: a systematic review and meta-analysis > Discussion
What the sources say
- Not checked yetcites [4] Townsend, L. et al. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann. Am. Thorac. Soc. https://doi.org/10.1513/AnnalsATS.202009-1175OC (2021). source
- Partly supportedcites [23] Townsend, L. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 15, e0240784. https://doi.org/10.1371/journal.pone.0240784 (2020). sourceExperimental — accuracy not yet measured
Townsend et al. (2020) confirm persistent fatigue after the acute phase of SARS-CoV-2 infection, but at a median of 10 weeks (~70 days) from symptom onset (Abstract; Results, Participant characteristics: median interval 72 days, IQR 62-87; Table 2 'Days since Symptom Onset' medians 71 and 73). The only passage reaching beyond ~84 days is Table 1's follow-up band '>84 days (12 weeks)' (38 participants, 22 fatigued), and the Discussion explicitly frames the report as a 'medium time point' and calls for future longitudinal work 'to describe the persistence of fatigue at six months and beyond'. No passage in our copy states fatigue at or beyond 100 days from first symptom, so that specific qualifier of the citing sentence is not supported by this source. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The prevalence of 55 long-term effects was estimated”
- Also stated in: § Prevalence of long-term effects in COVID-19 patients · plain
“We identified a total of 55 long-term effects associated with COVID-19 in the literature reviewed”
§ More than 50 long-term effects of COVID-19: a systematic review and meta-analysis > Abstract
plainstates an associationn = 47,910- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Prevalence of long-term effects in COVID-19 patients · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It was estimated that 80% of the infected patients with SARS-CoV-2 developed one or more long-term symptoms.”
- Also stated in: § Prevalence of long-term effects in COVID-19 patients · plain
“The meta-analysis of the studies (n = 7) that included an estimate for one symptom or more reported that 80% (95% CI 65–92) of the patients with COVID-19 have long-term symptoms.”
- Also stated in: § Discussion · boosted
“This systematic review and meta-analysis shows that 80% (95% CI 65–92) of individuals with a confirmed COVID-19 diagnosis continue to have at least one overall effect beyond 2 weeks following acute infection.”
§ More than 50 long-term effects of COVID-19: a systematic review and meta-analysis > Abstract
boostedn = 7- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Prevalence of long-term effects in COVID-19 patients · plain
27 more claims
Create a free account to see all 54 claims and to verify the 18 references still open.
- It may state two separate claims as one. 7
- Probably not a substantial claim. 17
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mental health symptoms such as depression, anxiety and sleep problems are commonly observed in individuals suffering from acute COVID-19 infection to post-COVID-19 syndrome.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These mental health symptoms persist even after the acute stage of the disease.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“Mental health symptoms are common in reports of a post-covid syndrome (4, 6).”
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407
Barendregt, J. J., Doi, S. A., Lee, Y. Y., Norman, R. E., & Vos, T. (2013) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2013-203104 · Cited by 2,169
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912
Management of post-acute covid-19 in primary care
Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020) · BMJ · doi:10.1136/bmj.m3026 · Cited by 1,689
Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30462-4 · Cited by 1,484
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., Gibbs, K. W., Erickson, H. L., Steingrub, J. S., Smithline, H. A., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6930e1 · Cited by 1,319
Garrigues, E., Janvier, P., Kherabi, Y., Le Bot, A., Hamon, A., Gouze, H., Doucet, L., Berkani, S., Oliosi, E., Mallart, E., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.08.029 · Cited by 1,157
Cited by
Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac136 · Cited by 1,366
Symptoms and risk factors for long COVID in non-hospitalized adults
Subramanian, A., Nirantharakumar, K., Hughes, S., Myles, P., Williams, T., Gokhale, K. M., Taverner, T., Chandan, J. S., Brown, K., Simms-Williams, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01909-w · Cited by 1,065
Phetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01113-x · Cited by 1,015
Raveendran, A. V., Jayadevan, R., & Sashidharan, S. (2021) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2021.04.007 · Cited by 921
O'Mahoney, L. L., Routen, A., Gillies, C., Ekezie, W., Welford, A., Zhang, A., Karamchandani, U., Simms-Williams, N., Cassambai, S., Ardavani, A., et al. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101762 · Cited by 791
Metadata
- Authors
- Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S.
- Affiliations
- Universidad Nacional Autónoma de México (MX)
- Emory University (US)
- Houston Methodist (US)
- Corresponding author
- Villapol, Sonia
- ORCID
- Venue
- Scientific Reports
- Published
- 2021-08-09
- Volume
- 11
- Issue
- 1
- Pages
- 16144-16144
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC8352980
- OpenAlex
- W3133517424
- Cited by
- 2,757
- References
- 51
- Citations by year
- 2026: 130 · 2025: 278 · 2024: 510 · 2023: 728 · 2022: 776 · 2021: 331
- FWCI
- 75.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by-nc-nd)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Houston Methodist Research Institute
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- long COVID, long-term effects of COVID-19, SARS-CoV-2, post-acute sequelae, fatigue, headache, attention disorders, hair loss, dyspnea, prevalence, multidisciplinary care, rehabilitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1038/s41598-021-95565-8
- The paper
- Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021). More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-021-95565-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.